Results showed increased expression of ENO3 (Figure 9A), MORC2 (Figure 9B), SUCLG2 (Figure 9C) and ELOVL6 (Figure 9D), and decreased expression of CPT2 (Figure 9E) in all examined colon adenocarcinoma cell lines. This evidence concerns the gene SUCLG2 and colon adenocarcinoma.